MDT

97.34

+1.43%↑

A

142.76

+3.7%↑

VEEV

220.6

+0.53%↑

HQY

93.37

+2.55%↑

PHR.US

17.12

+5.29%↑

MDT

97.34

+1.43%↑

A

142.76

+3.7%↑

VEEV

220.6

+0.53%↑

HQY

93.37

+2.55%↑

PHR.US

17.12

+5.29%↑

MDT

97.34

+1.43%↑

A

142.76

+3.7%↑

VEEV

220.6

+0.53%↑

HQY

93.37

+2.55%↑

PHR.US

17.12

+5.29%↑

MDT

97.34

+1.43%↑

A

142.76

+3.7%↑

VEEV

220.6

+0.53%↑

HQY

93.37

+2.55%↑

PHR.US

17.12

+5.29%↑

MDT

97.34

+1.43%↑

A

142.76

+3.7%↑

VEEV

220.6

+0.53%↑

HQY

93.37

+2.55%↑

PHR.US

17.12

+5.29%↑

Search

Lisata Therapeutics

Cerrado

1.87 0.54

Resumen

Variación precio

24h

Actual

Mínimo

1.8199999999999998

Máximo

1.98

Métricas clave

By Trading Economics

Empleados

26

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-5.8M

14M

Apertura anterior

1.33

Cierre anterior

1.87

Lisata Therapeutics Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 ene 2026, 18:06 UTC

Principales Movimientos del Mercado

LifeMD Shares Rise After Company Offers Novo Nordisk's Wegovy

5 ene 2026, 23:51 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 ene 2026, 23:51 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

5 ene 2026, 23:51 UTC

Charlas de Mercado

Nikkei May Rise After Gains on Wall Street -- Market Talk

5 ene 2026, 23:42 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Lower on Likely Technical Correction -- Market Talk

5 ene 2026, 21:52 UTC

Noticias de Eventos Importantes

Oil Stocks, Banks Push Dow to New Record -- WSJ

5 ene 2026, 21:51 UTC

Noticias de Eventos Importantes

Palantir Stock Jumps. How It Benefited from the Venezuela Raid. -- Barrons.com

5 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

5 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 ene 2026, 21:38 UTC

Noticias de Eventos Importantes

Stock Market Today: Dow Jumps to Record After U.S. Captures Venezuela's Maduro -- WSJ

5 ene 2026, 21:09 UTC

Adquisiciones, fusiones, absorciones

SGH, Steel Dynamics Won't Need to Raise Equity to Fund Transaction

5 ene 2026, 21:09 UTC

Adquisiciones, fusiones, absorciones

SGH, Steel Dynamics to Fund Transaction With Cash, Available Debt Financing

5 ene 2026, 21:08 UTC

Adquisiciones, fusiones, absorciones

SGH Proposes Minimum One Board Position for BlueScope Directors to Maintain Continuity

5 ene 2026, 21:06 UTC

Adquisiciones, fusiones, absorciones

SGH, Steel Dynamics Offer Values BlueScope's Equity at A$13.2 Billion

5 ene 2026, 21:06 UTC

Adquisiciones, fusiones, absorciones

SGH Would Retain Remainder of BlueScope's Operations if Deal Completes

5 ene 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

SGH Would Sell BlueScope's North American Operations to Steel Dynamics if Deal Completes

5 ene 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

SGH, Steel Dynamics Offering A$30.00/Share in Cash to Acquire BlueScope

5 ene 2026, 21:04 UTC

Adquisiciones, fusiones, absorciones

SGH, Steel Dynamics Make Takeover Offer for BlueScope Steel

5 ene 2026, 20:18 UTC

Charlas de Mercado

U.S. Natural Gas Extends Losses on Milder Weather Outlook -- Market Talk

5 ene 2026, 20:08 UTC

Charlas de Mercado

Venezuela Needs Billions in Investment for Oil-Production Growth -- Market Talk

5 ene 2026, 19:16 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Alberta Says Canada Needs to Expedite Pipeline Projects Following Trump's Venezuela Move -- Market Talk

5 ene 2026, 18:57 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Quick Return of Venezuelan Oil Barrels A Possibility -- Market Talk

5 ene 2026, 18:23 UTC

Charlas de Mercado

Moody's Should See Boost from Strong Debt Issuance Year -- Market Talk

5 ene 2026, 18:08 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 ene 2026, 18:08 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

5 ene 2026, 18:08 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Canadian Heavy Oil Producers at Risk From a Revitalized Venezuela -- Market Talk

5 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 ene 2026, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

5 ene 2026, 17:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

5 ene 2026, 17:08 UTC

Ganancias

Strategy Records $17.44 Billion Unrealized Loss in Fourth Quarter -- WSJ

Comparación entre iguales

Cambio de precio

Lisata Therapeutics previsión

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Finanzas

$

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
help-icon Live chat